Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein aggregation.

G Merlini1, V Bellotti, A Andreola

  • 1Biotechnology Research Laboratories, University Hospital IRCCS Policlinico San Matteo, Pavia, Italy. gmerlini@smatteo.pv.it

Clinical Chemistry and Laboratory Medicine
|February 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus.

Orphanet journal of rare diseases·2020
Same author

Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

European journal of neurology·2020
Same author

Periacetabular osteotomy for hip dysplasia treatment through a mini-invasive technique. Our results at mid-term in 131 cases.

Revista espanola de cirugia ortopedica y traumatologia (English ed.)·2020
Same author

Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7.

Journal of the neurological sciences·2019
Same author

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Journal of hematology & oncology·2018
Same author

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

Leukemia·2016
Same journal

Ethical evaluation of reflex and reflective testing in conformity with ISO 15189:2022 at the value-based laboratory medicine era.

Clinical chemistry and laboratory medicine·2026
Same journal

Emerging blood-based diagnostic strategies for tuberculosis.

Clinical chemistry and laboratory medicine·2026
Same journal

Homocitrulline and 3-year mortality in older hospitalised adults: an exploratory study.

Clinical chemistry and laboratory medicine·2026
Same journal

Impact of age partitioning on classification discordance in pediatric ferritin reference intervals.

Clinical chemistry and laboratory medicine·2026
Same journal

National implementation of LOINC: translation methodology and experience from the Polish laboratory terminology standardization project.

Clinical chemistry and laboratory medicine·2026
Same journal

Harmonization of measurement units: mission impossible or ethical imperative?

Clinical chemistry and laboratory medicine·2026
See all related articles

Protein misfolding causes diverse diseases, including neurodegenerative disorders like Alzheimer's. These conditions involve protein aggregates forming amyloid deposits, often complicating laboratory diagnosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Protein misfolding and aggregation are central to various diseases, collectively termed protein conformational diseases.
  • These diseases encompass neurodegenerative disorders (Alzheimer's, Parkinson's, Huntington's) and other conditions like cystic fibrosis and sickle cell anemia.
  • The hallmark is altered protein structure leading to aggregate formation, often amyloid fibrils.

Purpose of the Study:

  • To review the molecular mechanisms underlying protein misfolding and aggregation in disease.
  • To highlight the structural changes in proteins that lead to pathogenic aggregates.
  • To discuss the implications for disease pathogenesis and diagnostic challenges.

Main Methods:

  • Review of existing literature on protein conformational diseases.

Related Experiment Videos

  • Analysis of structural changes in amyloidogenic proteins.
  • Discussion of factors influencing protein structural instability and aggregation.

    • Main Results:

    • Protein conformational diseases arise from aberrant protein folding, resulting in aggregates.
    • Amyloid deposits are common supramolecular organizations of misfolded proteins.
    • Protein structural instability, influenced by mutations or environmental factors, is a key feature.

    Conclusions:

    • Protein misfolding and aggregation are critical pathogenic events in a range of debilitating diseases.
    • The structural instability of proteins contributes to the formation of toxic aggregates.
    • Diverse molecular mechanisms complicate the development of universal laboratory diagnostic approaches for these protein conformational diseases.